Vytrus Biotech (FRA:V5P) Institutional Ownership: 0.44% (As of Jul. 30, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:V5P Vytrus Biotech SA FRA:V5P
66 GF Score
Price €17.30
GF Value €6.87
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Vytrus Biotech Institutional Ownership?

Vytrus Biotech FRA:V5P 66 Institutional Ownership is 0.44% as of Jul. 30, 2026. GuruFocus rates FRA:V5P with a GF Score™ of 66/100 and a GF Value™ of €6.87 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Vytrus Biotech's institutional ownership is 0.44%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Vytrus Biotech's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Vytrus Biotech's Float Percentage Of Total Shares Outstanding is 0.00%.

Vytrus Biotech Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Vytrus Biotech's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vytrus Biotech Institutional Ownership Chart

Vytrus Biotech Historical Data

The historical data trend for Vytrus Biotech can be seen below:

2025-05-31 2025-06-30 2025-07-31 2025-08-31 2025-09-30 2025-10-31 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 0.11 0.37 0.41 0.41 0.41 0.40 0.44 0.38 0.44 0.44
FRA:V5P
66GF Score
Vytrus Biotech SA FRA:V5P
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vytrus Biotech Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.44% mean?
Vytrus Biotech (FRA:V5P) has a Institutional Ownership of 0.44% as of Jul. 30, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Vytrus Biotech and its competitors.
Is Vytrus Biotech's Institutional Ownership too high?
Vytrus Biotech's current Institutional Ownership is 0.44%. Overall, Vytrus Biotech has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vytrus Biotech's Institutional Ownership compare to VRTX and REGN?
Vytrus Biotech's Institutional Ownership of 0.44% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Vytrus Biotech and its competitors. Vytrus Biotech's current Institutional Ownership is 0.44%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vytrus Biotech stock overvalued right now?
Based on GuruFocus' analysis, Vytrus Biotech (FRA:V5P) is currently considered Significantly Overvalued. The stock's GF Value™ is €6.87, compared to a current price of €17.30 — trading 151.8% above its estimated fair value. The current Institutional Ownership is 0.44%. Vytrus Biotech's overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Vytrus Biotech (FRA:V5P), the current Institutional Ownership is 0.44% as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vytrus Biotech (FRA:V5P) Overvalued in 2026?

Based on GuruFocus' analysis, Vytrus Biotech stock appears to be overvalued. The current stock price of €17.30 is trading 151.8% above its estimated GF Value™ of €6.87. GuruFocus considers Vytrus Biotech to be Significantly Overvalued.

Key valuation signals for FRA:V5P:

  • Institutional Ownership: 0.44%
  • GF Value™: €6.87 vs. price of €17.30 (151.8% above fair value)
  • GF Score™: 66/100 with 2 warning signs

No single metric tells the full story. See the FRA:V5P stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vytrus Biotech Business Description

Other Exchanges VYT:Spain
Address Sant Gaieta 121, 2nd Floor, Terrassa, Barcelona, ESP, 08221
Vytrus Biotech SA develops natural active ingredients on an industrial scale. The natural actives offered by the company include Nectaria Lithops, Olea Vitae, Turmeric zen, Capilia Longa, Qura Noni.
66GF Score

Get the complete analysis for FRA:V5P

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€17.30
Price
€6.87
GF Value